Corrigendum to "Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes" [Eur. Urol. Focus (2023)].

Authors

Jennifer M Linehan, Providence Specialty Medical Group, Santa Monica, CA, USAFollow
Josh Gottlieb, Providence Specialty Medical Group, Santa Monica, CA, USA.Follow
Solomon L Woldu
Craig Labbate
Kyle Rose
Wade Sexton
Hristos Kaimakliotis
Joseph Jacob
Rian Dickstein
Alan Nieder
Marc Bjurlin
Mitchell Humphreys
Saum Ghodoussipour
Marcus Quek
Michael O'Donnell
Brian H Eisner
Adam S Feldman
Surena F Matin
Yair Lotan
Katie S Murray

Document Type

Article

Publication Date

8-26-2023

Publication Title

Eur Urol Focus

Keywords

california; santa monica

Clinical Institute

Cancer

Department

Oncology

Department

Urology

Recommended Citation

Linehan, Jennifer M; Gottlieb, Josh; Woldu, Solomon L; Labbate, Craig; Rose, Kyle; Sexton, Wade; Kaimakliotis, Hristos; Jacob, Joseph; Dickstein, Rian; Nieder, Alan; Bjurlin, Marc; Humphreys, Mitchell; Ghodoussipour, Saum; Quek, Marcus; O'Donnell, Michael; Eisner, Brian H; Feldman, Adam S; Matin, Surena F; Lotan, Yair; and Murray, Katie S, "Corrigendum to "Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes" [Eur. Urol. Focus (2023)]." (2023). Articles, Abstracts, and Reports. 7886.
https://digitalcommons.providence.org/publications/7886